454 related articles for article (PubMed ID: 33819186)
1. Suppressing the KIF20A/NUAK1/Nrf2/GPX4 signaling pathway induces ferroptosis and enhances the sensitivity of colorectal cancer to oxaliplatin.
Yang C; Zhang Y; Lin S; Liu Y; Li W
Aging (Albany NY); 2021 Mar; 13(10):13515-13534. PubMed ID: 33819186
[TBL] [Abstract][Full Text] [Related]
2. Fusobacterium nucleatum induces oxaliplatin resistance by inhibiting ferroptosis through E-cadherin/β-catenin/GPX4 axis in colorectal cancer.
Li B; Wei Z; Wang Z; Xu F; Yang J; Lin B; Chen Y; Wenren H; Wu L; Guo X; Liu Y; Wei Y
Free Radic Biol Med; 2024 Aug; 220():125-138. PubMed ID: 38657754
[TBL] [Abstract][Full Text] [Related]
3. Nrf2 inhibition reverses resistance to GPX4 inhibitor-induced ferroptosis in head and neck cancer.
Shin D; Kim EH; Lee J; Roh JL
Free Radic Biol Med; 2018 Dec; 129():454-462. PubMed ID: 30339884
[TBL] [Abstract][Full Text] [Related]
4. SNHG4-mediated PTEN destabilization confers oxaliplatin resistance in colorectal cancer cells by inhibiting ferroptosis.
Li SQ; Xu WT; Yin YX; Wei HT; Li KZ; Xie MZ; Lv F; Xie LY; Hu BL
Apoptosis; 2024 Jun; 29(5-6):835-848. PubMed ID: 38573492
[TBL] [Abstract][Full Text] [Related]
5. Ibuprofen induces ferroptosis of glioblastoma cells via downregulation of nuclear factor erythroid 2-related factor 2 signaling pathway.
Gao X; Guo N; Xu H; Pan T; Lei H; Yan A; Mi Y; Xu L
Anticancer Drugs; 2020 Jan; 31(1):27-34. PubMed ID: 31490283
[TBL] [Abstract][Full Text] [Related]
6. Nrf2 inhibition increases sensitivity to chemotherapy of colorectal cancer by promoting ferroptosis and pyroptosis.
Huang Y; Yang W; Yang L; Wang T; Li C; Yu J; Zhang P; Yin Y; Li R; Tao K
Sci Rep; 2023 Sep; 13(1):14359. PubMed ID: 37658132
[TBL] [Abstract][Full Text] [Related]
7. Colorectal Tumors Require NUAK1 for Protection from Oxidative Stress.
Port J; Muthalagu N; Raja M; Ceteci F; Monteverde T; Kruspig B; Hedley A; Kalna G; Lilla S; Neilson L; Brucoli M; Gyuraszova K; Tait-Mulder J; Mezna M; Svambaryte S; Bryson A; Sumpton D; McVie A; Nixon C; Drysdale M; Esumi H; Murray GI; Sansom OJ; Zanivan SR; Murphy DJ
Cancer Discov; 2018 May; 8(5):632-647. PubMed ID: 29500295
[TBL] [Abstract][Full Text] [Related]
8. In vitro siRNA-mediated GPX4 and AKT1 silencing in oxaliplatin resistance cancer cells induces ferroptosis and apoptosis.
Golbashirzadeh M; Heidari HR; Aghamolayi AA; Fattahi Y; Talebi M; Khosroushahi AY
Med Oncol; 2023 Aug; 40(10):279. PubMed ID: 37632628
[TBL] [Abstract][Full Text] [Related]
9. The induction of ferroptosis by impairing STAT3/Nrf2/GPx4 signaling enhances the sensitivity of osteosarcoma cells to cisplatin.
Liu Q; Wang K
Cell Biol Int; 2019 Nov; 43(11):1245-1256. PubMed ID: 30811078
[TBL] [Abstract][Full Text] [Related]
10. DJ-1 upregulates the Nrf2/GPX4 signal pathway to inhibit trophoblast ferroptosis in the pathogenesis of preeclampsia.
Liao T; Xu X; Ye X; Yan J
Sci Rep; 2022 Feb; 12(1):2934. PubMed ID: 35190654
[TBL] [Abstract][Full Text] [Related]
11. Correction for: Suppressing the KIF20A/NUAK1/Nrf2/GPX4 signaling pathway induces ferroptosis and enhances the sensitivity of colorectal cancer to oxaliplatin.
Yang C; Zhang Y; Lin S; Liu Y; Li W
Aging (Albany NY); 2021 Jul; 13(14):19077. PubMed ID: 34314378
[No Abstract] [Full Text] [Related]
12. APE1 inhibition enhances ferroptotic cell death and contributes to hepatocellular carcinoma therapy.
Du Y; Zhou Y; Yan X; Pan F; He L; Guo Z; Hu Z
Cell Death Differ; 2024 Apr; 31(4):431-446. PubMed ID: 38418695
[TBL] [Abstract][Full Text] [Related]
13. Cetuximab promotes RSL3-induced ferroptosis by suppressing the Nrf2/HO-1 signalling pathway in KRAS mutant colorectal cancer.
Yang J; Mo J; Dai J; Ye C; Cen W; Zheng X; Jiang L; Ye L
Cell Death Dis; 2021 Nov; 12(11):1079. PubMed ID: 34775496
[TBL] [Abstract][Full Text] [Related]
14. Targeting critical pathways in ferroptosis and enhancing antitumor therapy of Platinum drugs for colorectal cancer.
Wang G; Wang JJ; Zhi-Min Z; Xu XN; Shi F; Fu XL
Sci Prog; 2023; 106(1):368504221147173. PubMed ID: 36718538
[TBL] [Abstract][Full Text] [Related]
15. Hemin mitigates contrast-induced nephropathy by inhibiting ferroptosis via HO-1/Nrf2/GPX4 pathway.
Gao Z; Zhang Z; Gu D; Li Y; Zhang K; Dong X; Liu L; Zhang J; Chen J; Wu D; Zeng M
Clin Exp Pharmacol Physiol; 2022 Aug; 49(8):858-870. PubMed ID: 35598290
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of SRSF9 enhances the sensitivity of colorectal cancer to erastin-induced ferroptosis by reducing glutathione peroxidase 4 expression.
Wang R; Su Q; Yin H; Wu D; Lv C; Yan Z
Int J Biochem Cell Biol; 2021 May; 134():105948. PubMed ID: 33609745
[TBL] [Abstract][Full Text] [Related]
17. Naringenin alleviates myocardial ischemia/reperfusion injury by regulating the nuclear factor-erythroid factor 2-related factor 2 (Nrf2) /System xc-/ glutathione peroxidase 4 (GPX4) axis to inhibit ferroptosis.
Xu S; Wu B; Zhong B; Lin L; Ding Y; Jin X; Huang Z; Lin M; Wu H; Xu D
Bioengineered; 2021 Dec; 12(2):10924-10934. PubMed ID: 34699317
[TBL] [Abstract][Full Text] [Related]
18. FOXA2 Suppression by TRIM36 Exerts Anti-Tumor Role in Colorectal Cancer Via Inducing NRF2/GPX4-Regulated Ferroptosis.
Liu X; Yan C; Chang C; Meng F; Shen W; Wang S; Zhang Y
Adv Sci (Weinh); 2023 Dec; 10(35):e2304521. PubMed ID: 37875418
[TBL] [Abstract][Full Text] [Related]
19. SIRT6 silencing overcomes resistance to sorafenib by promoting ferroptosis in gastric cancer.
Cai S; Fu S; Zhang W; Yuan X; Cheng Y; Fang J
Biochem Biophys Res Commun; 2021 Nov; 577():158-164. PubMed ID: 34530350
[TBL] [Abstract][Full Text] [Related]
20. Britanin relieves ferroptosis-mediated myocardial ischaemia/reperfusion damage by upregulating GPX4 through activation of AMPK/GSK3β/Nrf2 signalling.
Lu H; Xiao H; Dai M; Xue Y; Zhao R
Pharm Biol; 2022 Dec; 60(1):38-45. PubMed ID: 34860639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
